PCM
CVS icon

Palouse Capital Management’s CVS Health CVS Stock Holding History

Palouse Capital Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.52M Sell
14,687
-259
-2% -$23.1K 0.95% 44
2026
Q1 		$1.07M Sell
14,946
-1,141
-7% -$87.9K 0.71% 53
2025
Q4 		$1.28M Sell
16,087
-588
-4% -$46.4K 0.82% 51
2025
Q3 		$1.26M Buy
16,675
+234
+1% +$16K 0.8% 54
2025
Q2 		$1.13M Sell
16,441
-6,433
-28% -$422K 0.75% 53
2025
Q1 		$1.55M Sell
22,874
-188
-0.8% -$11.3K 1.06% 41
2024
Q4 		$1.04M Sell
23,062
-558
-2% -$31.3K 0.69% 52
2024
Q3 		$1.49M Sell
23,620
-1,263
-5% -$73.7K 0.94% 45
2024
Q2 		$1.47M Sell
24,883
-512
-2% -$32K 0.99% 44
2024
Q1 		$2.03M Sell
25,395
-1,352
-5% -$103K 1.34% 31
2023
Q4 		$2.11M Buy
26,747
+1,896
+8% +$135K 1.49% 26
2023
Q3 		$1.74M Sell
24,851
-428
-2% -$30.3K 1.29% 40
2023
Q2 		$1.75M Sell
25,279
-1,605
-6% -$114K 1.22% 40
2023
Q1 		$2M Sell
26,884
-7,212
-21% -$605K 1.35% 34
2022
Q4 		$12.9M Sell
34,096
-1,978
-5% -$191K 0.89% 33
2022
Q3 		$3.44M Sell
36,074
-1,712
-5% -$169K 1.96% 17
2022
Q2 		$3.5M Sell
37,786
-485
-1% -$47.3K 1.74% 22
2022
Q1 		$3.87M Sell
38,271
-706
-2% -$74.2K 1.7% 18
2021
Q4 		$4.02M Sell
38,977
-1,320
-3% -$122K 1.72% 20
2021
Q3 		$3.42M Sell
40,297
-1,187
-3% -$99.4K 1.52% 23
2021
Q2 		$3.46M Sell
41,484
-529
-1% -$43.3K 1.51% 24
2021
Q1 		$3.16M Buy
42,013
+555
+1% +$40.4K 1.39% 31
2020
Q4 		$2.83M Sell
41,458
-4,231
-9% -$275K 1.5% 29
2020
Q3 		$2.67M Buy
+45,689
New +$2.84M 1.49% 32
2020
Q1 		– Sell
-120,192
Closed -$8.93M – 79
2019
Q4 		$8.93M Sell
120,192
-10,072
-8% -$707K 3.38% 3
2019
Q3 		$8.22M Sell
130,264
-3,464
-3% -$205K 3.05% 4
2019
Q2 		$7.29M Buy
133,728
+51,233
+62% +$2.76M 2.62% 4
2019
Q1 		$4.45M Sell
82,495
-66
-0.1% -$4.07K 1.71% 26
2018
Q4 		$5.41M Sell
82,561
-1,080
-1% -$80.6K 2.14% 13
2018
Q3 		$6.58M Sell
83,641
-610
-0.7% -$43.6K 2.3% 11
2018
Q2 		$5.42M Buy
84,251
+1,913
+2% +$126K 1.84% 23
2018
Q1 		$5.12M Buy
82,338
+44,900
+120% +$3.22M 1.71% 26
2017
Q4 		$2.71M Sell
37,438
-392
-1% -$28.5K 0.92% 45
2017
Q3 		$3.08M Buy
37,830
+381
+1% +$30.1K 1.03% 44
2017
Q2 		$3.01M Sell
37,449
-316
-0.8% -$25K 1.1% 41
2017
Q1 		$2.96M Buy
37,765
+594
+2% +$47.4K 1.13% 39
2016
Q4 		$2.93M Sell
37,171
-2,079
-5% -$168K 1.2% 41
2016
Q3 		$3.49M Sell
39,250
-1,299
-3% -$123K 1.49% 31
2016
Q2 		$3.88M Sell
40,549
-1,096
-3% -$109K 1.58% 29
2016
Q1 		$4.32M Sell
41,645
-1,408
-3% -$137K 1.76% 19
2015
Q4 		$4.21M Buy
43,053
+270
+0.6% +$26.4K 1.64% 21
2015
Q3 		$4.13M Sell
42,783
-15,928
-27% -$1.67M 1.59% 21
2015
Q2 		$6.16M Sell
58,711
-4,590
-7% -$469K 2.17% 10
2015
Q1 		$6.53M Sell
63,301
-2,392
-4% -$242K 2.3% 7
2014
Q4 		$6.33M Sell
65,693
-19,483
-23% -$1.72M 2.23% 7
2014
Q3 		$6.78M Sell
85,176
-1,872
-2% -$148K 2.59% 6
2014
Q2 		$6.56M Sell
87,048
-3,254
-4% -$246K 2.42% 7
2014
Q1 		$6.76M Sell
90,302
-3,837
-4% -$271K 2.54% 5
2013
Q4 		$6.74M Sell
94,139
-1,790
-2% -$115K 2.57% 5
2013
Q3 		$5.44M Buy
95,929
+15,287
+19% +$911K 2.2% 10
2013
Q2 		$4.61M Buy
+80,642
New +$4.67M 1.96% 16

Other funds holding CVS

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Palouse Capital Management's CVS Position: Q2 2026 in Review

Palouse Capital Management reduced its CVS Health (CVS) stake by 1.7% in Q2 2026, selling an estimated $23.1K and leaving 14,687 shares worth $1.52M. The position accounts for 0.95% of the portfolio, ranked #44.

Palouse Capital Management first reported a position in CVS in Q2 2013 and has held it in 51 quarters since. The position peaked at $12.9M in Q4 2022. 459 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Palouse Capital Management held 14,687 shares of CVS Health worth $1.52M as of Q2 2026.
  • Palouse Capital Management sold 259 CVS Health shares in Q2 2026, an estimated $23.1K.
  • CVS Health made up 0.95% of Palouse Capital Management's portfolio in Q2 2026, its #44 holding.
  • Palouse Capital Management first reported a position in CVS Health in Q2 2013 and has held it in 51 quarters since.
  • Palouse Capital Management's CVS Health position peaked at $12.9M in Q4 2022.
  • 459 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Palouse Capital Management's 13F filing for Q2 2026, filed 8 Jul 2026.